Enhanced Embolic Capture Devices for Minimally Invasive Catheter-Based Interventions

Publication ID: 24-11857209_0006_PTD
Published: November 07, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Embolic Capture Devices for Minimally Invasive Catheter-Based Interventions,” Published Technical Disclosure No. 24-11857209_0006_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857209_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,209.

Summary of the Inventive Concept

The present inventive concept discloses novel improvements to embolic capture devices for treating blocked blood vessels, enhancing their efficiency, safety, and effectiveness in minimally invasive catheter-based interventions.

Background and Problem Solved

The original patent disclosed embolic capture devices with limitations in terms of embolus containment, radial strength, and flexibility. The present inventive concept addresses these limitations by introducing an improved mesh basket design, novel strut patterns, and thrombolytic coatings, reducing the risk of distal complications and enhancing embolus removal efficiency.

Detailed Description of the Inventive Concept

The inventive concept comprises a catheter-based emboli removal device with an improved mesh basket design featuring enhanced radial strength and flexibility. The device incorporates a novel strut pattern that enables efficient embolus capture and removal. Additionally, the device can be deployed with a proximal-to-distal motion, reducing the risk of embolus dislodgement. A detachable embolic capture device can be released from the catheter, allowing for more precise control and reduced risk of vessel damage. Furthermore, the device can be coated with a thrombolytic agent, enhancing the efficacy of embolus removal and reducing the risk of re-occlusion.

Novelty and Inventive Step

The novel features of the inventive concept include the improved mesh basket design, novel strut patterns, and thrombolytic coatings, which provide a non-obvious solution to the limitations of the original patent. The proximal-to-distal deployment motion and detachable embolic capture device also introduce new and innovative aspects to the field.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the mesh basket design, strut patterns, and thrombolytic coatings. Additionally, the device could be adapted for use in different vascular systems, such as coronary or peripheral vessels.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the field of minimally invasive catheter-based interventions for treating blocked blood vessels. The device could be marketed to hospitals, clinics, and medical professionals specializing in interventional cardiology and neurology.

CPC Classifications

SectionClassGroup
A A61 A61B17/22012
A A61 A61B17/221
A A61 A61B2017/22038
A A61 A61B2017/22084

Field of Art

Interventional medical devices, specifically minimally invasive catheter-based embolic capture systems for neurovascular and peripheral vascular interventions, requiring expertise in medical device design, interventional radiology, and vascular pathology

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or interventional radiologist with advanced training in medical device design, familiar with catheter-based interventional techniques, material science, and vascular anatomy, possessing knowledge of existing embolic capture technologies

Obviousness Rationale

A person having ordinary skill would recognize that the PTD's variations represent predictable engineering modifications to the source patent's core embolic capture device design. The disclosed improvements in mesh basket geometry, deployment mechanism, and thrombolytic coating are logical extensions of known medical device optimization strategies. These variations would be considered routine design iterations by a skilled practitioner seeking to enhance device performance and patient outcomes.

Obvious Combinations & Variations

Source Patent Element
Elongated stent body with multiple cell configurations and strut profiles
PTD Variation
Novel strut pattern enhancing radial strength and flexibility
Obviousness Reasoning
A PHOSITA would recognize that modifying strut geometry to improve device performance is a standard engineering approach in medical device design, representing a predictable variation within known design parameters
Source Patent Element
Catheter-based embolic capture device with axial rotation capability
PTD Variation
Proximal-to-distal deployment motion to reduce embolus dislodgement
Obviousness Reasoning
Modifying device deployment mechanics to improve clinical safety is an obvious design optimization that would be apparent to a skilled practitioner seeking to minimize procedural complications
Source Patent Element
Minimally invasive vascular intervention device
PTD Variation
Thrombolytic agent coating to enhance embolus removal efficacy
Obviousness Reasoning
Applying pharmacological treatments to medical devices is a known technique for improving therapeutic outcomes, representing a straightforward combination of mechanical and pharmaceutical approaches
Source Patent Element
Stent body with multiple cell configurations
PTD Variation
Detachable embolic capture device for precise control
Obviousness Reasoning
Creating modular medical devices with improved release mechanisms is a predictable engineering solution for enhancing procedural flexibility and reducing potential vessel damage
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this published technical disclosure (PTD) would be considered obvious extensions of US Patent 11857209, rendering potential patent claims covering similar embolic capture device configurations unpatentable. The disclosed technical modifications represent routine engineering optimizations that would be apparent to a person having ordinary skill in interventional medical device design, lacking the requisite non-obviousness for patent protection.

Original Patent Information

Patent NumberUS 11,857,209
TitleDevices and methods for treating blocked blood vessels
Assignee(s)SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC.